Abstract:The chromium(III) complex, Cr(C7H3NO4)2·C4H12N5 (1), was synthesised by chelating chromium with dipicolinic (H2dipic) in methanol, and its structure was characterised using elemental analysis (EA), spectroscopy (infrared, UV–visible, and fluorescence) and single-crystal X-ray method. The density functional theoretical (DFT) computation was performed using the Gaussian 09 package. The stability of solution at different temperatures and pH values, the electrochemical, morphological and thermal properties of complex 1 were discussed. The preliminary bioactivities of complex 1 in streptozotocin (STZ)-induced type 2 diabetes mellitus (T2DM) mice were investigated using daily oral gavage for 12 weeks. The cytotoxicity was assessed using the methyl thiazolyl tetrazolium (MTT) assays, and the acute toxicity experiment test was carried out on healthy C57BL/6 mice with this complex. The complex 1 crystallised in the monoclinic system with the space group P2(1)/n, R1 = 0.0642. The DFT-optimised structure of complex 1 was in excellent agreement with the X-ray crystal structure. The complex 1 exhibited good physical and chemical properties and beneficial function on blood glucose and lipid metabolism for T2DM. The antidiabetic activity of chromium(III) might be associated with chromium(VI). Furthermore, the cytotoxicity and the acute toxicity experiments showed that the complex 1 was hypotonic and secure to organism. The study of complex 1 showed that the prepared complex on the basis of H2dipic and Met could inhibit hyperglycaemia and hyperlipidaemia in vivo and did not have potential toxicity. These results demonstrated that the complex 1 might provide an important reference for the development of functional hypoglycaemic foods or pharmaceuticals of T2DM.

Synthesis and characterization of baicalin-chromium (III) complex

Synthesis and Characterization of Baicalin-Chromium(Ⅲ) Complex

Evaluation of Hypoglycemic Activity and Sub-Acute Toxicity of the Novel Biochanin A-Chromium(III) Complex

Characterization of Transformation Pattern of Baicalin Using UV Spectrometric Analysis and Multivariate Curve Resolution

Research on Synthesis and Biological Activities of Baicalin-La( Ⅲ)、Y(Ⅲ) Complexes

Chromium(Iii) Complexes of D-Glucosaminic Acid and Their Effect on Decreasing Blood Sugar in Vivo

Preparation of a Novel Oat β-Glucan–Chromium(III) Complex and Its Hypoglycemic Effect and Mechanism

Potential antidiabetic molecule involving a new chromium(III) complex of dipicolinic and metformin as a counter ion: Synthesis, structure, spectroscopy, and bioactivity in mice

Supramolecular interaction between berberine hydrochloride and baicalin in aqueous solution: Reaction kinetics, spectral analysis and dynamic simulation

Complexation of Baicalin with Ferrous (II) and Its Characterization

Efficient Synthesis of Baicalin and Its Analogs

Synthesis, biological activity and toxicity of chromium(III) metformin complex as potential insulin-mimetic agent in C57BL/6 mice

Baicalin-berberine complex nanocrystals orally promote the co-absorption of two components

A Newly Synthetic Chromium Complex – Chromium(phenylalanine)3 Improves Insulin Responsiveness and Reduces Whole Body Glucose Tolerance

Preparation, Characterization and in Vivo Evaluation of Formulation of Baicalein with Hydroxypropyl-Beta-Cyclodextrin

Baicalin and its aglycone: a novel approach for treatment of metabolic disorders

Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes

Characterization and Evaluation in Vivo of Baicalin-Nanocrystals Prepared by an Ultrasonic-Homogenization-fluid Bed Drying Method

Enzymatic Synthesis of α-Glucosyl-Baicalin through Transglucosylation via Cyclodextrin Glucanotransferase in Water

Electrochemical investigations of baicalin and DNA–baicalin interactions

In vitro absorption and lipid-lowering activity of baicalin esters synthesized by whole-cell catalyzed esterification